Milestone Pharmaceuticals CFO Amit Hasija receives $2.5M in 2019

Milestone Pharmaceuticals reports 2019 executive compensation

By ExecPay News

Published: May 5, 2020

Milestone Pharmaceuticals reported fiscal year 2019 executive compensation information on May 5, 2020.
In 2019, four executives at Milestone Pharmaceuticals received on average a compensation package of $1.2M, a 19% increase compared to previous year.
Average pay of disclosed executives at Milestone Pharmaceuticals
Amit Hasija, Chief Financial Officer, received $2.5M in total. 93.23% of Hasija's compensation, or $2.3M, was in option awards. Hasija also received $45.5K in non-equity incentive plan and $121.3K in salary.
Timothy Maness, Chief Accounting Officer, received a compensation package of $1.1M. 73.65% of the compensation package, or $818.6K, was in option awards.
Joseph Oliveto, Chief Executive Officer, earned $785K in 2019, a 45% decrease compared to previous year.
Francis Plat, Chief Medical Officer, received $579.1K in 2019, which decreases by 9% compared to 2018.

Related executives

Joseph Oliveto

Milestone Pharmaceuticals

Chief Executive Officer

Amit Hasija

Milestone Pharmaceuticals

Chief Financial Officer

Francis Plat

Milestone Pharmaceuticals

Chief Medical Officer

Timothy Maness

Milestone Pharmaceuticals

Chief Accounting Officer

You may also like

Source: SEC filing on May 5, 2020.